-
Cornell suspends frat parties after alleged gang rape
-
Judge extends halt to Trump's golf course tree-cutting
-
Man City deserve to keep titles, says PSG's Luis Enrique
-
Milan's Saelemaekers set for lenghty spell out after ankle surgery
-
Regulator 'will resign' if any political interference in Man City case
-
Nvidia says to invest in French medical website
-
Microsoft's Brad Smith calls for 'real and effective' AI safety standards
-
Real Madrid's Mourinho has 'trust' in referees despite complaints
-
Anthropic warns of AI 'worms' spreading across smart gadgets
-
Mendis, Shanaka star in Sri Lanka consolation T20I win
-
Big US banks report strong earnings and stay bullish on AI
-
Demonstrations backing France's protesting students gather strength
-
Iraola backs Barcola, Wirtz to come good for Liverpool
-
Trump says US Senate as hard to defend as House in midterms
-
In a first, AI helps UK lawmaker find her voice in parliament
-
Suspected Russian drones hit two ships off Bulgaria, 11 missing
-
Pope Leo in Rome hospital for lung operation
-
Tech stocks slide on AI jitters
-
EU watchdog says smart glasses must give 'clear warnings' when recording
-
Trump asks Greece ambassador to resign amid ethics scandal
-
Houthis say Saudi Arabia strikes oil site in Yemen's capital
-
New White House spokeswoman heavy on Trump praise, light on questions in debut
-
France roiled by marches in support of protesting students
-
Emery urges Villa to make most of reduced home comfort
-
Goldman Sachs profits jump as CEO says no plans to exit
-
Flavio Bolsonaro visits father under house arrest ahead of Brazil runoff
-
Apple unveils HomeView smart display in renewed home push
-
France, Eq. Guinea in standoff over luxury Paris mansion
-
Novelist Thelyson Orelien denies AI use, admits plagiarism 'mistakes'
-
'Holding our ground': Israel demolishes dozens of Bedouin homes
-
Trump asks Greece ambassador to resign amid bribery scandal: White House
-
Hazlewood takes six as Australia beat South Africa in 1st Test
-
11 missing after ships struck off Bulgaria in latest Black Sea attack
-
Saudi coalition tells Sanaa residents to flee site before operation
-
France budget debate faces rocky start as Socialists vow to fight
-
Zverev defies 'physical issues' to reach Shanghai Masters quarter-finals
-
AI could 'change the stakes' on bioweapons: UK spy chief
-
'We're not giving up': Activist Thunberg joins France student protests
-
Sweden centre-left leader fails to form government
-
Man City captain Dias defends celebrations after Liverpool win
-
EU economy chief doubtful Russian diesel exports will affect prices
-
B2PRIME Expands Tier-1 Access and Liquidity Architecture for Sophisticated Institutional Flow
-
Capital International Highlights Multilingual Access to Its Platform as European Economic Conditions Diverge
-
STARTRADER Adds 48 US Stock CFDs with 24-Hour Weekday Trading
-
Hazlewood takes six as Australia win first Test
-
'Ink' director Danny Boyle slams Trump's Truth Social 'lies'
-
Pope Leo admitted to hospital for lung operation
-
Coach Kovac extends contract at Dortmund until 2029
-
Hungary cuts anti-LGBTQ measures from Orban-era law
-
Activist Thunberg joins France student rally after violence at protests
Many Laser Specialists Consider the 1927nm Thulium Laser One of the Most Useful Wavelengths Available
ROCKWALL, TX / ACCESS Newswire / June 27, 2026 / Saratoga Technologies, L.L.C., on February 16, 2026, unveiled Laserase™, an FDA-cleared 1927nm Thulium laser system. This platform combines micro-ablative and non-ablative treatments to address pigmentation disorders, photoaging, fine lines, wrinkles, acne scarring, uneven texture, sun damage, melasma, freckles, post-inflammatory hyperpigmentation (PIH), actinic keratosis, enlarged pores, skin laxity, and hair/scalp conditions. It is safe for all Fitzpatrick types (I-VI) with minimal PIH risk.
Laserase™ stimulates collagen remodeling, eliminates recurring consumable costs, and creates micro-channels for deeper absorption of serums, PRP, exosomes, and biologics.
Key Benefits:
Superior pigment correction for melasma, freckles, sun spots, and PIH.
Zero disposables for reduced overhead.
Versatile single platform for broad concerns, including non-surgical lifting and laser-assisted drug delivery.
Safe for ALL SKIN TYPES
Early adopters report 3-5× higher revenue and demand for services like "Thulium Glow".
"Laserase™ elevates practices with transformative results and simplicity, expanding the clinical capabilities of thulium laser technology while remaining accessible and efficient," said Jason Lake, President of Saratoga Technologies, L.L.C. "We designed the platform to help providers deliver consistent outcomes and broaden the services they offer patients."
Laserase™ is now available for demonstration and purchase in the United States, with exclusive previews, priority delivery, and IRS Section 179 eligibility.
About Saratoga Technologies, L.L.C.:
An innovator in aesthetic laser solutions, delivering proven technologies to enhance patient care and practice efficiency nationwide.
Contact Information:

Tom Pallone, C.E.O., Jason Lake, President,
Saratoga Technologies, L.L.C. Saratoga Technologies, L.L.C.
Phone: (888) 263-1113
Website: www.Thulium1927.com or www.Laserase1927.com
Website: https://saratogatec.com/
Media Contact Information
Saratoga Technologies, L.L.C.
[email protected]
SOURCE: Saratoga Technologies, L.L.C.
View the original press release on ACCESS Newswire
H.Gonzales--AT